Cutaneous manifestations of human and murine leishmaniasis
The leishmaniases are diseases caused by pathogenic protozoan parasites of the genus
Leishmania. Infections are initiated when a sand fly vector inoculates Leishmania parasites …
Leishmania. Infections are initiated when a sand fly vector inoculates Leishmania parasites …
Pro-and anti-inflammatory cytokines in cutaneous leishmaniasis: a review
Cutaneous leishmaniasis (CL) is caused by different species of the genus Leishmania. Pro-
and anti-inflammatory cytokines play different roles in resistance/susceptibility and the …
and anti-inflammatory cytokines play different roles in resistance/susceptibility and the …
Host–pathogen interaction in leishmaniasis: immune response and vaccination strategies
Leishmaniasis is a zoonotic and vector-borne infectious disease that is caused by the genus
Leishmania belonging to the trypanosomatid family. The protozoan parasite has a digenetic …
Leishmania belonging to the trypanosomatid family. The protozoan parasite has a digenetic …
Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T …
Visceral leishmaniasis (VL) is one of the most neglected tropical diseases for which no
vaccine exists. In spite of extensive efforts, no successful vaccine is available against this …
vaccine exists. In spite of extensive efforts, no successful vaccine is available against this …
Wound healing in cutaneous leishmaniasis: a double edged sword of IL-10 and TGF-β
Immune responses have a crucial role during the wound healing process in cutaneous
leishmaniasis (CL). However, there are several paradoxes in immunity against CL. On the …
leishmaniasis (CL). However, there are several paradoxes in immunity against CL. On the …
Therapeutic vaccines for leishmaniasis
A Khamesipour - Expert Opinion on Biological Therapy, 2014 - Taylor & Francis
Introduction: Numerous therapeutic strategies are used to treat leishmaniasis. The treatment
of cutaneous leishmaniasis (CL) is solely depends on antimonate derivatives with safety …
of cutaneous leishmaniasis (CL) is solely depends on antimonate derivatives with safety …
The binomial parasite-host immunity in the healing process and in reactivation of human tegumentary leishmaniasis
F Conceição-Silva, J Leite-Silva… - Frontiers in …, 2018 - frontiersin.org
Leishmaniasis is a vector-borne infectious disease caused by different species of protozoa
from the Leishmania genus. Classically, the disease can be classified into two main clinical …
from the Leishmania genus. Classically, the disease can be classified into two main clinical …
Development of a Novel Formulation with Hypericin To Treat Cutaneous Leishmaniasis Based on Photodynamic Therapy in In Vitro and In Vivo Studies
A Montoya, A Daza, D Muñoz, K Ríos… - Antimicrobial agents …, 2015 - Am Soc Microbiol
An evaluation of the leishmanicidal activity in vitro and in vivo of hypericin, an expanded-
spectrum photosensitizer found in Hypericum perforatum, is presented. Hypericin was …
spectrum photosensitizer found in Hypericum perforatum, is presented. Hypericin was …
Chronic generalized fibrotic skin lesions from disseminated leishmaniasis caused by Leishmania martiniquensis in two patients from northern Thailand infected with …
S Chiewchanvit, N Tovanabutra… - British Journal of …, 2015 - academic.oup.com
Background Leishmaniasis is a newly emerging infection in Thailand. Most of the previous
human cases have presented with the clinical features of visceral leishmaniasis and were …
human cases have presented with the clinical features of visceral leishmaniasis and were …
[HTML][HTML] Humoral immunity in leishmaniasis–Prevention or promotion of parasite growth?
Leishmaniasis can present as a “spectrum” of clinical outcomes. There is evidence that
these divergent clinical outcomes are attributable to genetic differences in the human host …
these divergent clinical outcomes are attributable to genetic differences in the human host …